Dana Mariani | Association for Accessible Medicines
GRx+Biosims - No-cost FDA workshop limited to first 100 who sign up. Act now!

Dana Mariani

Director, Policy
Dana Mariani

Dana Mariani is Director, Policy, of the Association for Accessible Medicines. She works with leadership to identify issues affecting AAM members’ interests and develops strategic policy positions. Dana develops and manages research opportunities projects as well as writes testimony, public comments, policy papers and other materials in support of these positions. She also collaborates with AAM’s communications team on content that advances the strategic goals and mission of AAM.

Prior to joining AAM in September 2018, Dana was part a cross-functional Project Management Organization team at Guidehouse (the public sector arm of PwC), supporting the Centers for Medicare and Medicaid (CMS) Quality Payment Program (QPP). Before that, she held positions at CareMetx in Bethesda MD and AAM member Lupin Pharmaceuticals in Morristown, NJ.

Dana is an MBA candidate at American University’s Kogod School of Business. She has a BA and an MSPH from the Johns Hopkins University. 

Latest Tweets

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.